Edwards Lifesciences Corp. Stock
With only a change of -€0.020 (-0.020%) the Edwards Lifesciences Corp. price is nearly unchanged from yesterday.
The stock is one of the favorites of our community with 24 Buy predictions and 1 Sell predictions.
With a target price of 87 € there is a slightly positive potential of 6.12% for Edwards Lifesciences Corp. compared to the current price of 81.98 €.
Our community identified positive and negative aspects for Edwards Lifesciences Corp. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Edwards Lifesciences Corp. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Edwards Lifesciences Corp. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Edwards Lifesciences Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp. | -0.020% | -2.739% | -6.138% | 3.708% | 17.734% | 2.024% | 368.831% |
| QuidelOrtho Corp. | -0.540% | -5.641% | -15.596% | -55.416% | -45.739% | -63.815% | - |
| Boston Scientific | 0.780% | 0.787% | 2.269% | 37.605% | 24.417% | 80.638% | 105.062% |
| Illumina Inc. | 3.490% | -0.965% | -11.240% | -45.489% | -12.125% | -66.798% | -60.267% |
Comments
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Royal Bank of Canada from $95.00 to $101.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Mizuho from $95.00 to $105.00. They now have a "buy" rating on the stock.
Show more
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) was upgraded by analysts at OTR Global from a "mixed" rating to a "positive" rating.
Show more
Ratings data for EW provided by MarketBeat
News
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen Healthcare Conference on Tuesday, March 5, 2024.
Bernard Zovighian, chief executive officer, and
Edwards Lifesciences Reports Fourth Quarter Results
Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2023.
Highlights and Outlook
-
Q4 sales grew 14 percent to $1.53 billion; constant currency1